GEORGES ELIAS has a total of 16 patent applications. Its first patent ever was published in 2000. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, measurement and pharmaceuticals are CARIS LIFE SCIENCES LUXEMBOURG HOLDINGS S A R L, MURACA PATRICK J and PICOBELLA LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 15 | |
#2 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement | |
#3 | Pharmaceuticals | |
#4 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Measuring microorganism processes | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Combinatorial chemistry | |
#6 | Medical preparations | |
#7 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Georges Elias | 16 |
#2 | Bonneau Anne-Marie | 10 |
#3 | Boucher Claudia | 2 |
#4 | Prinos Panagiotis | 2 |
#5 | Lanthier Julie | 1 |
#6 | Dallaire Frederic | 1 |
#7 | Serfass Lucile | 1 |
#8 | Lantheir Julie | 1 |
#9 | Benquet Corinne | 1 |
Publication | Filing date | Title |
---|---|---|
US2009233293A1 | Ttk directed diagnostics for neoplastic disease | |
US2009253138A1 | Kif20a directed diagnostics for neoplastic disease | |
US2009233295A1 | Trim59 directed diagnostics for neoplastic disease | |
US2011020370A1 | Slc7a5 directed diagnostics and therapeutics for neoplastic disease | |
US2009233294A1 | Uhrf1 directed diagnostics for neoplastic disease | |
US2009155790A1 | Crab-pii directed diagnostics for neoplastic disease | |
US2009068670A1 | Stratifin directed diagnostics for neoplastic disease | |
US2009069549A1 | Protein Extraction buffer, a kit comprising it and method of its use | |
US2007243548A1 | Calumenin-directed diagnostics and therapeutics for cancer and chemotherapeutic drug resistance | |
US2006188507A1 | Methods for identifying chemotherapeutic resistance in non-hematopoietic tumors |